Diabetes News and Research

Latest Diabetes News and Research

REBOOT trial finds no benefit of beta blockers after uncomplicated heart attacks

Beta blockers-drugs commonly prescribed for a range of cardiac conditions, including heart attacks-provide no clinical benefit for patients who have had an uncomplicated myocardial infarction with preserved heart function.

30 Aug 2025

Insights into clinical features and genetic variants of Cornelia de Lange syndrome in China

Cornelia de Lange syndrome (CdLS) is a rare genetic disorder with symptoms, including facial anomalies (such as fused eyebrows, short nose, upturned nose tip, and downturned mouth corners), growth retardation, small head (microcephaly), developmental delays, cognitive impairments, excess hair growth, and limb anomalies.

29 Aug 2025

Exploring the untapped potential of DNA glycosylation

Recent advancements in glycobiology have challenged the traditional understanding of molecular interactions, and a new study published in Engineering titled "Can DNA be glycosylated?" by Wei Wang further explores this emerging field.

29 Aug 2025

Alzheimer’s research uncovers a new therapeutic pathway for the memory-robbing malady

The gut contains the largest collection of immune cells in the body. New research at the Buck Institute shows that some of those immune cells travel along the brain/gut axis in a mouse model of Alzheimer's disease (AD) providing a potential new therapeutic pathway for the memory-robbing malady.

29 Aug 2025

Inherited DNA changes can cause hormone imbalance in women with polycystic ovary syndrome

Increased testosterone levels are a consistent hormonal abnormality in women with polycystic ovary syndrome (PCOS). This study identified specific DNA variants in the gene DENND1A, which increase testosterone production in PCOS.

29 Aug 2025

Inflammation marker can help identify heart risk in women without traditional factors

Cardiologists have long known that up to half of all heart attacks and strokes occur among apparently healthy individuals who do not smoke and do not have high blood pressure, high cholesterol, or diabetes, the "standard modifiable risk factors" which doctors often call "SMuRFs."

29 Aug 2025

What are the benefits of chewing gum beyond oral health?

Chewing gum offers health benefits beyond oral care, enhancing performance and recovery, but research gaps for children and seniors need addressing.

29 Aug 2025

Healthy gut bacteria capsules show long-term benefits for obese teenagers

Can a capsule of healthy gut bugs change the future of obesity treatment? New findings from the University of Auckland’s Liggins Institute suggest it might.

29 Aug 2025

UNSW researchers identify key protein that regulates fat storage in cells

UNSW research has shed light on how cells in the body manage and store fat, potentially offering new insights into health.

29 Aug 2025

PREVENT equations provide more accurate risk estimates and support personalized hypertension care

Using the Predicting Risk of cardiovascular disease EVENTs (PREVENT™) equations provides more accurate risk estimates and supports personalized treatment for adults with high blood pressure or hypertension, according to a new scientific statement published today in the American Heart Association's peer-reviewed journals Circulation and Hypertension, and in JACC, the flagship journal of the American College of Cardiology.

28 Aug 2025

Ultra-processed foods harm reproductive and metabolic health

Over the past 50 years, rates of obesity and type-2 diabetes have soared, while sperm quality has plummeted. Driving these changes could be the increasing popularity of ultra-processed foods, which have been linked to a range of poor health outcomes.

28 Aug 2025

Gut disorders forecast Alzheimer’s and Parkinson’s risk years before diagnosis

Study maps clinical, genetic, and proteomic links between gut-brain disorders and neurodegeneration, showing how diabetes, vitamin D deficiency, and bowel disorders forecast Alzheimer’s and Parkinson’s years in advance. Multimodal models in biobanks highlight early detection and personalized prevention opportunities.

28 Aug 2025

AI and routine lab tests offer a more accurate prediction of genetic disease risk

When genetic testing reveals a rare DNA mutation, doctors and patients are frequently left in the dark about what it actually means.

28 Aug 2025

Metabolic health plays larger role than weight gain in pregnancy outcomes

Metabolic health before and during pregnancy may have a bigger influence on risks for mother and baby than simply controlling weight gain.

28 Aug 2025

Late dinners and missed breakfasts tied to higher osteoporosis risk

People who skip breakfast and eat late dinners may have an increased risk of developing osteoporosis, according to a new study published in the Journal of the Endocrine Society.

28 Aug 2025

Wayne State project advances efforts toward automated diabetes care

Despite advances in insulin therapy and automated delivery systems, people with Type 1 diabetes (T1D) still face a daily struggle: manually dosing insulin before meals.

28 Aug 2025

Food scientists identify worst additives for longevity: flavours, sweeteners, and colourings top list

Researchers analyzing data from 186,744 UK Biobank participants found that ultra-processed food consumption and specific additives, such as sugars, sweeteners, flavorings, and colorings, were linked to higher mortality. Some processing aids showed risks, while gelling agents appeared protective.

27 Aug 2025

Increasing numbers of bariatric surgery patients turn to GLP-1 drugs

Bariatric surgery is usually effective on its own for weight loss, but an increasing proportion of patients who undergo bariatric surgery start taking one of the new glucagon-like 1 peptide receptor agonist (GLP-1) weight-loss drugs in the years after their surgery, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

27 Aug 2025

GLP-1 receptor agonists improve heart failure outcomes and reduce environmental impact

New research has found that the use of GLP-1 receptor agonists, a class of medications commonly prescribed for patients with obesity and diabetes, reduces the environmental footprint of healthcare and clinical outcomes when used to treat heart failure.

27 Aug 2025

Do GLP-1 drugs shrink your muscles? New study explains the risks and what to do

GLP-1 receptor agonists are transforming obesity and diabetes care, but may reduce skeletal muscle mass, raising concerns about sarcopenic obesity. This comprehensive review explores the mechanisms, clinical implications, and mitigation strategies, including exercise, protein intake, and adjunct therapies.

26 Aug 2025

Previous
1
...
10
11
12
13
14
15
16
...
1913
Next

Diabetes News and Research

Latest Diabetes News and Research

REBOOT trial finds no benefit of beta blockers after uncomplicated heart attacks

Insights into clinical features and genetic variants of Cornelia de Lange syndrome in China

Exploring the untapped potential of DNA glycosylation

Alzheimer’s research uncovers a new therapeutic pathway for the memory-robbing malady

Inherited DNA changes can cause hormone imbalance in women with polycystic ovary syndrome

Inflammation marker can help identify heart risk in women without traditional factors

What are the benefits of chewing gum beyond oral health?

Healthy gut bacteria capsules show long-term benefits for obese teenagers

UNSW researchers identify key protein that regulates fat storage in cells

PREVENT equations provide more accurate risk estimates and support personalized hypertension care

Ultra-processed foods harm reproductive and metabolic health

Gut disorders forecast Alzheimer’s and Parkinson’s risk years before diagnosis

AI and routine lab tests offer a more accurate prediction of genetic disease risk

Metabolic health plays larger role than weight gain in pregnancy outcomes

Late dinners and missed breakfasts tied to higher osteoporosis risk

Wayne State project advances efforts toward automated diabetes care

Food scientists identify worst additives for longevity: flavours, sweeteners, and colourings top list

Increasing numbers of bariatric surgery patients turn to GLP-1 drugs

GLP-1 receptor agonists improve heart failure outcomes and reduce environmental impact

Do GLP-1 drugs shrink your muscles? New study explains the risks and what to do

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Diabetes News and Research

Latest Diabetes News and Research

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in